Notify me when Robert W. Duggan files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PLSE | Pulse Biosciences, Inc. | Common Stock, par value $0.001 per share | 70.6% | $783M | 48.8M | Robert W. Duggan | Dec 18, 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|